DA

Didier Allaer

Europe, Liege, Belgium, Liège

Description

Didier Allaer - CEO @ Diagenode

Investor Profile

Didier Allaer has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series Unknown rounds (top funding stages).
  • Majority of deals are located in Belgium.
  • Strong thematic focus on Biopharma, Biotechnology, Pharmaceutical.

Stage Focus

  • Series Unknown (100%)

Country Focus

  • Belgium (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Didier Allaer frequently co-invest with?

Meusinvest (Noshaq)
Europe, Liege, Belgium, Liège
Co-Investments: 1
Fund+
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 1
S.R.I.W.
Europe, Liege, Belgium, Liège
Co-Investments: 1
N
Europe, Liege, Belgium, Eupen
Co-Investments: 1
SFPI-FPIM
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 1
QI
Europe, Oost-Vlaanderen, Belgium, Ghent
Co-Investments: 1

Which angels does Didier Allaer often collaborate with?

FB
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Shared Deals: 1
JS
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Shared Deals: 1
RT
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Shared Deals: 1
Shared Deals: 1

What are some of recent deals done by Didier Allaer?

EyeD Pharma

Liège, Liege, Belgium

EyeD Pharma is a pharmaceutical company dedicated to the development of innovative drug products in ophthalmology.

BiopharmaBiotechnologyPharmaceutical
Series UnknownDec 24, 2021
Amount Raised: $50,951,260